USFDA classifies inspection at Cipla Kurkumbh facility as VAI Ruchika Sharma13 July 2024 2:55 PM ISTMumbai: Cipla has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has classified the routine current...
Cipla Patalganga facility gets VAI classification from USFDA Ruchika Sharma26 Jun 2024 12:30 PM ISTMumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...
Cipla Goa facility gets 6 USFDA observations Ruchika Sharma22 Jun 2024 3:31 PM ISTMumbai: Pharma major, Cipla, has received six inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) after...
Cipla EU to infuse additional EUR 3 million in Ethris Ruchika Sharma19 Jun 2024 2:53 PM ISTMumbai: Cipla Limited has announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited will invest an additional EUR 3...
Cipla bags USFDA nod for Lanreotide Injection for Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors Ruchika Sharma22 May 2024 12:35 PM ISTCipla's Lanreotide injection is indicated for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors.
Cipla to futher invest up to Rs 26 crore in Achira Labs Ruchika Sharma16 May 2024 5:30 PM ISTMumbai: Cipla Limited has announced that it has signed definitive agreements for further investment of up to Rs 26 crore (approx.) in Optionally...
Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO Ruchika Sharma11 May 2024 11:30 AM ISTBengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...
Cipla gets 1 inspectional observation from USFDA for Maha facility Ruchika Sharma9 May 2024 11:06 AM ISTMumbai: Pharma giant Cipla has informed through a recent BSE filing that the Company has received 1 inspectional observation in Form 483...
Cipla, Glenmark recall products from American market over manufacturing issues Ruchika Sharma6 May 2024 11:09 AM ISTNew Delhi: Glenmark and Cipla are recalling products from the American market over manufacturing issues, as per the US health regulator.According to...
Cipla Health to acquire Ivia Beaute's cosmetics, personal care distribution and marketing business for Rs 130 crore Ruchika Sharma16 April 2024 4:07 PM ISTMumbai: Cipla Limited has announced that Cipla Health Limited, the wholly owned subsidiary and consumer healthcare arm of the Company, has...
Cipla gets 6 USFDA observations for Maha facility Ruchika Sharma5 April 2024 11:51 AM ISTMumbai: Cipla has received six inspectional observations in Form 483 from the United States Food and Drug Administration (USFDA) at the...
Cipla gets CDSCO nod to market novel antibiotic Plazomicin in India, to launch under brand name Zemdri Ruchika Sharma5 March 2024 12:11 PM ISTMumbai: Cipla Limited has received approval from the Central Drugs Standard Control Organization (CDSCO) to market the novel antibiotic...
